🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 4 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/09/2021 52,49 52,72 50,97 51,78 +3,52% 3,33% 1.115.500
14/09/2021 50,86 51,06 49,50 50,02 -0,46% 3,07% 998.600
13/09/2021 52,30 52,36 50,19 50,25 -4,05% 4,15% 778.300
10/09/2021 55,23 55,43 52,32 52,37 -4,95% 5,62% 421.300
09/09/2021 57,01 57,38 54,88 55,10 -3,94% 4,39% 462.600
08/09/2021 59,27 59,82 57,32 57,36 -3,60% 4,22% 566.500
07/09/2021 59,48 60,04 58,94 59,50 +0,69% 1,85% 540.800
03/09/2021 59,80 59,80 57,80 59,09 -1,19% 3,34% 376.500
02/09/2021 58,32 60,04 58,22 59,80 +2,54% 3,12% 609.600
01/09/2021 60,00 60,08 57,36 58,32 -2,20% 4,53% 517.400
31/08/2021 57,19 59,96 57,19 59,63 +4,45% 4,84% 574.500
30/08/2021 56,93 58,14 56,63 57,09 +0,48% 2,64% 323.300
27/08/2021 54,24 57,28 53,84 56,82 +4,74% 6,34% 459.100
26/08/2021 52,43 54,87 52,29 54,25 +3,08% 4,93% 552.000
25/08/2021 51,30 52,74 51,10 52,63 +2,53% 3,21% 608.600
24/08/2021 50,00 51,85 50,00 51,33 +2,76% 3,70% 417.200
23/08/2021 49,61 50,48 49,33 49,95 +2,06% 2,32% 387.800
20/08/2021 47,46 48,96 47,43 48,94 +3,18% 3,22% 375.600
19/08/2021 47,24 47,66 46,38 47,43 -0,67% 2,71% 359.900
18/08/2021 49,25 49,77 47,71 47,75 -2,89% 4,18% 313.400
17/08/2021 48,21 49,21 47,84 49,17 -0,02% 2,84% 196.300
16/08/2021 48,79 49,95 47,68 49,18 +0,45% 4,65% 290.800
13/08/2021 49,50 50,72 48,61 48,96 -1,19% 4,26% 305.800
12/08/2021 50,71 50,71 49,10 49,55 -1,29% 3,17% 541.100
11/08/2021 50,56 50,92 48,79 50,20 -0,24% 4,21% 529.600
10/08/2021 54,97 54,97 49,96 50,32 -7,40% 9,11% 423.200
09/08/2021 51,66 54,80 51,50 54,34 +6,51% 6,39% 908.800
06/08/2021 48,70 51,20 46,84 51,02 +0,12% 8,95% 1.352.000
05/08/2021 49,16 51,58 48,75 50,96 +3,66% 5,76% 809.900
04/08/2021 49,41 50,99 49,03 49,16 -0,51% 3,97% 281.200